IMMUNOCARD STAT
E. COLI 0157 Plus
Laboratory News
December 2000
INTENDED USE:
The Immunocard STAT! E. coli 0157 Plus is a rapid test for the
detection of antigens from Shiga toxin-producing E. coli 0157 as an aid
in the diagnosis of E. coli 0157:H7 infection. The test can be used to
directly test stool specimens, or confirmatory stool cultures grown in
MacConkey broth or on SMAC plates. The test is now currently performed
routinely on all stool specimens submitted for culture, which yield growth on
the SMAC plate.
EXPLANATION:
Eschericia coli is a common microorganism found in normal human flora.
While many different serotypes have been identified, certain strains have
acquired genes for toxins from other bacterial species via bacteriophage
plasmids. Shiga toxin producing E. coli 0157 usually carries one or
more genes for Shiga toxin, placing it in a category of pathogens known as
Shiga toxin-producing enterohemorrhagic E. coli (STEC). STEC strains of
E. coli cause a wide spectrum of human diseases, including bloody and
non-bloody diarrhea, hemorrhagic colitis, kidney failure, hemolytic uremic
syndrome (HUS) and death. Morbidity and mortality rates in children, infants
and the elderly are especially high. In addition, many states and institutions
require a negative test prior to readmitting infected children to schools or
day-care facilities. Outbreaks attributed to E. coli 0157 infection
have most commonly been associated with undercooked beef and dairy products,
but have also been traced to leaf lettuce, radish sprouts, alfalfa sprouts,
unpasteurized cider and contaminated water.
To date, E. coli 0157:H7 has been the
most commonly described STEC serotype. The CDC recommends that all patients with
bloody stools submitted for routine stool culture be examined for the presence
of E. coli 0157:H7. Some investigators recommend that all stools
submitted for routine stool culture be examined for E. coli 0157:H7. Most
sorbitol nonfermenting E. coli 0157 are motile and possess the H7
antigen. Occasionally, a sorbitol-nonfermenting strain of E. coli 0157 is
either nonmotile, or motile with a nontypable flagellar antigen. Clinical
laboratory evaluation of a strain need not include H7 antigen determination.
Sorbitol-non-fermenting E. coli 0157 should be considered pathogenic,
whether or not the H7 antigen is detected. Determination of H7 may be helpful
epidemiologically, or for state and federal reporting purposes.
Immunocard STAT! E. coli 0157 Plus
was designed for the rapid and
accurate detection of Shiga toxin-producing E. coli O157. Accurate and
rapid detection of Shiga toxin-producing E. coli O157 is necessary to
prevent further spread of the organism, avoid unnecessary procedures such as
surgery and to guide treatment decisions.
LIMITATIONS OF THE PROCEDURE:
Test results should be used in conjunction with information available from
the patient clinical evaluation and other diagnostic procedures.
A negative test result indicates the absence of Shiga toxin-producing E.
coli 0157 antigens or that the levels of antigens are below that which can
be detected by this test. Further testing should be performed with negative
specimens to determine the cause of diarrhea. Optimal sensitivity is obtained
by culture confirmatory methods.
Many states require a negative STEC or E. coli 0157 test result
before a child can return to day care. For this purpose, to reduce the risk of
sending infectious children back into these environments, a culture
confirmatory method should be utilized.
Laboratories should comply with all local state and federal regulations for
reporting STEC or E. coli 0157 disease.
EXPECTED VALUES:
Shiga-toxin producing E. coli 0157 causes both sporadic and epidemic
outbreaks of disease. While the incidence of disease peaks in the summer
months, cases occur year round. Due to the focal nature of the disease,
incidence values range widely with geographic location, from zero to 3-4% in
severe outbreaks. For this reason, predictive values for the ImmunoCard
STAT! E. coli 0157 Plus test are subject to variation. The table
below gives the expected predictive values based upon incidence.
0157Incidence |
StoolPPV |
StoolNPV |
MACPPV |
MACNPV |
SMACPPV |
SMACNPV |
4.0% |
75.5% |
99.2% |
100% |
100% |
100% |
100% |
3.0% |
69.6% |
99.4% |
100% |
100% |
100% |
100% |
2.0% |
60.2% |
99.6% |
100% |
100% |
100% |
100% |
1.0% |
42.8% |
99.8% |
100% |
100% |
100% |
100% |
0.5% |
27.1% |
99.9% |
100% |
100% |
100% |
100% |
0.2% |
12.9% |
100% |
100% |
100% |
100% |
100% |
0.1% |
6.9% |
100% |
100% |
100% |
100% |
100% |
PERFORMANCE CHARACTERISTICS:
The ImmunoCard STAT! E. coli 0157 Plus was evaluated at six
locations. ImmunoCard STAT! E. coli 0157 Plus was tested on
direct stool, 24 hour broth cultures and on sorbitol negative colonies from
SMAC plates. In the table below,ImmunoCard STAT! E. coli 0157 Plus results
are compared to latex testing of sorbitol negative colonies from a SMAC plate.
0157culture |
StoolPOS |
StoolNEG |
MACPOS |
MAC NEG |
SMACPOS |
SMACNEG |
POS |
341 |
77 |
17 |
0 |
20 |
0 |
NEG |
5 |
359 |
0 |
261 |
0 |
32 |
Sens |
82% |
78-85% |
100% |
81-100% |
100% |
83-100% |
Spec |
99% |
97-100% |
100% |
99-100% |
100% |
89-100% |
|